Stock screenerAll disclosures →
EDGAR →
GMED
Conviction 17HealthcareScan · Mon, Jul 20, 2026GMED$76.08-1.19%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 2.09M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price76.08
Change-1.19%
Gap-0.16%
Rel volume0.98×
Avg volume2.06M
Avg $ vol163.31M
SMA 2079.48
SMA 5079.75
SMA 20083.09
Price vs 50-4.60%
Price vs 200-8.43%
MA stackbearish
50/200 crossdeath · 8d
Supertrenddown · 86.94
RSI (14)44
MACD hist-0.11
MACD crossbear · 0d
Stoch %K / %D20 / 32
ADX (14)17
+DI / −DI19 / 25
RSI divergence—
MACD divergence—
ATR %+4.43%
ADR %4.16%
52w high96.82
52w low51.89
From 52w high-21.42%
Above 52w low+46.62%
New 52w highNo
SqueezeOff
Bollinger width14.63%
%B0.21
Donchian pos14.18%
Donchian high86.34
Donchian low74.39
AVWAP (52w high)85.15
vs AVWAP high-10.65%
AVWAP (52w low)78.88
vs AVWAP low-3.54%
OBV trendFlat
Chaikin MF (20)0.06
Today vs 20d0.98×
Avg vol (14d)2.09M
Avg vol (20d)2.06M
Avg $ vol (20d)163.31M
Market cap10.33B
RS 3m (vs SPY)-22.92%
RS 6m (vs SPY)-24.39%
RS line new highNo
Trend template4/8
Technical rank23.8
1 week-4.60%
1 month+0.88%
3 months-20.13%
6 months-18.97%
1 year+32.20%
YTD-12.85%
P/E19.20
P/B2.18
P/S3.51
P/FCF17.54
EPS3.92
Div yield—
ROE11.37%
ROA9.89%
Debt/Eq—
Current4.56
EV/EBITDA12.91
Gross margin34.72%
Net margin18.30%
Rev growth16.65%
EPS growth422.28%
Price target106.20
Target upside39.59%
Analyst ratingBuy
Institutional112.08%
Ent. value9.77B
Revenue759.85M
Net income124.3M
Gross profit369.65M
Free cash flow588.77M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNYSE
Shares out—
Employees6K
ListedFri, Aug 3, 2012
Free float132.06M
Float %97.6%
Short interest7.41M
Days to cover3.6d
Short volume72.3%
Squeeze score49 / 100
Next earningsThu, Aug 6, 2026 · after (17d)
EPS forecast$1.12 · 4 est
Last EPS vs est$1.12 vs $0.92
Last surprise+21.7% beat
Setup gradeD
Conviction17 / 100
Pattern quality—
Tech rank23.8 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance84.76
Support74.67
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GMED · 4 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Lisa McClain house · R · MI · traded 2025-06-24 | Sell | $1K–$15K | 2025-06-24 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-07-10 | Sell | $1K–$15K | 2025-07-10 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-17 | Buy | $1K–$15K | 2025-06-17 | 2025-08-13 | |
 Josh Gottheimer house · D · NJ · traded 2025-04-09 | Sell | $1K–$15K | 2025-04-09 | 2025-05-14 |
Insider activity
SEC Form 4 transactions in GMED · 2 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Davidar David D Director · Stock Option (Right to Buy Class A Common Stock) · 2026-06-05 | Exercise | 25K | $0 | 2026-06-05 | 2026-06-09 |
Davidar David D Director · Class A Common Stock · 2026-06-05 | Sell | 25K | $2.0M | 2026-06-05 | 2026-06-09 |
Davidar David D Director · Class A Common Stock · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-09 |
Davidar David D Director · Class A Common Stock · 2026-06-05 | Exercise | 25K | $657K | 2026-06-05 | 2026-06-09 |
RHOADS ANN D Director · Class A Common Stock · 2026-06-04 | Exercise | 25K | $657K | 2026-06-04 | 2026-06-08 |
RHOADS ANN D Director · Stock Option (Right to Buy Class A Common Stock) · 2026-06-04 | Exercise | 25K | $0 | 2026-06-04 | 2026-06-08 |
SEC filings
EDGAR filings in GMED · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.